WCLC 2020: Advances in Targeted Therapy for NSCLC

home / thoracic-night-live / wclc-2020-advances-in-targeted-therapy-for-nsclc
Nicholas Rohs, MD

EP. 1: HER2-Directed Advances in Lung Cancer

April 9th 2021

Thoracic Night Live is devoted to spotlighting the biggest topics in lung cancer and pivotal studies discussed at medical meetings throughout the year.

Isabel Preeshagul, DO, MBS, a medical oncologist at Memorial Sloan Kettering Cancer Center, and Joshua K. Sabari, MD, an assistant professor in the Department of Medicine at NYU Grossman School of Medicine

EP. 2: Updates in EGFR+ NSCLC, Including Uncommon EGFR Mutations

April 9th 2021

Nicholas C. Rohs, MD, Isabel Preeshagul, DO, MBS, and Joshua K. Sabari, MD, discuss data from the IASLC 2020 World Conference on Lung Cancer focused on EGFR-positive non–small cell lung cancer.

Nicholas C. Rohs, MD

EP. 3: What's Happening in KRAS G12C+ NSCLC?

April 9th 2021

Nicholas C. Rohs, MD, Isabel Preeshagul, DO, MBS, and Joshua K. Sabari, MD, discuss the latest findings in KRAS G12C–positive non–small cell lung cancer.

Nicholas C. Rohs, MD, Isabel Preeshagul, DO, MBS, and Joshua K. Sabari, MD

EP. 4: Meeting MET-Amplified NSCLC With Progress

April 9th 2021

Nicholas C. Rohs, MD, Isabel Preeshagul, DO, MBS, and Joshua K. Sabari, MD, discuss promising agents in the treatment of patients with non–small cell lung cancer with MET amplification.

Nicholas C. Rohs, MD

EP. 5: Liquid Biopsies and Molecular Testing in NSCLC

April 9th 2021

Nicholas C. Rohs, MD, Isabel Preeshagul, DO, MBS, and Joshua K. Sabari, MD, discuss the significance of molecular testing in clinical practice and the evolution of liquid biopsies in lung cancer treatment.